Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-001302
Filing Date
2025-01-06
Accepted
2025-01-06 16:05:09
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2432241-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2432241-1_3seq1.xml 3 1561
  Complete submission text file 0001104659-25-001302.txt   2946
Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Issuer) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)

Mailing Address 122 BURNET STREET OAKVILLE A6 L6K 1C1
Business Address
Jarratt Christopher Kenneth (Reporting) CIK: 0002050992 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42451 | Film No.: 25511046